United States · FDA National Drug Code directory
Opill
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0113-8101_fb2ad1e4-4e8a-4cee-a6e8-a823401dd8fe
- Product NDC
- 0113-8101
- Form
- TABLET
- Composition / generic term
- norgestrel
- Labeler
- L. Perrigo Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240304
- Source listing expiry
- 20261231
Source-listed ingredients
- NORGESTREL — .075 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (0113-8101-01) / 28 TABLET in 1 BLISTER PACK · 0113-8101-01
- 3 BLISTER PACK in 1 CARTON (0113-8101-03) / 28 TABLET in 1 BLISTER PACK · 0113-8101-03
- 4 BLISTER PACK in 1 PACKAGE (0113-8101-04) / 28 TABLET in 1 BLISTER PACK · 0113-8101-04
- 6 BLISTER PACK in 1 CARTON (0113-8101-06) / 28 TABLET in 1 BLISTER PACK · 0113-8101-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →